INQOVI
CEDAZURIDINE and DECITABINE
Listed by Taiho Pharmaceutical Co., Ltd.
- Strength
- 100 mg/1, 35 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Nucleoside Metabolic Inhibitor
What it contains
- Cedazuridine 100 mg/1
- Decitabine 35 mg/1
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Nucleoside Metabolic Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 64842-0727 |
| FDA application | NDA212576 |
| RxNorm concept | 2384457 |
| Package sizes listed | 1 |
| Marketed since | July 2020 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.